Phase 3 CAR-T vs SOC in Relapse Refractory Multiple Myeloma (RRMM)
Discover how effective we are in immunophenotyping for a Car-T therapy take a look at this case study
Discover how effective we are in immunophenotyping for a Car-T therapy take a look at this case study
As your partner, Cerba Research empowers you to bring new, life-changing therapies to patients worldwide.